On May 17, 2017, the New England Venture Capital Association (NEVCA) hosted one of Boston’s biggest award shows. For the past five years, the NEVYs have brought together the growing Tech and Life Science communities, all under one roof. This year’s event was held at Boston’s House of Blues.
Awards were presented to Tech and Life Science finalists in the following categories:
Healthcare & Life Science
- Deal of the Year: Jounce Therapeutics, Inc.
- Digital Health Company of the Year: Rest Devices
- Entrepreneur of the Year: Kurt Graves, Intarcia Therapeutics
- Exit of the Year: Nimbus Apollo
- Fund of the Year: Third Rock Ventures
- Hottest Early Stage Startup – Therapeutics: Magenta Therapeutics
- Hottest Early Stage Startup – Tools & Tech: 3Derm
- Rising Star VC: Michael Gladstone, Atlas Venture
- Angel of the Year: Joe Caruso
- Clean Tech Company of the Year: Sense
- Entrepreneur of the Year: Ric Fulop, Desktop Metal
- Fund of the Year: Highland Capital Partners
- Hottest Early Stage Startup: nuTonomy
- Next Pillar Tech Company: Turbonomic
- Rising Star Entrepreneur: Liz Powers, ArtLifting
- Rising Star VC: Juan Luis Leung-Li, General Catalyst
CBRE/NE’s Amarante & Brinch present Third Rock Ventures with the Fund of the Year award for Healthcare & Life Science (Courtesy of the NEVCA)
Congratulations to all of this year’s NEVY nominees and award winners!
For more information about the NEVCA and CBRE/New England’s expertise in Tech and Life Science communities, please reach out to Adam Brinch or Nick Amarante. Follow the NEVCA on Twitter for updates on upcoming events and other networking opportunities.
Short on time? Here are the highlights of our first quarter Boston Suburban Office MarketView. To request the full report, fill out the form at the bottom of this post.
Reebok’s headquarters relocation to downtown Boston in Q3 2017 will result in another large block of space becoming available in the Metro South market.
To begin the year, the Greater Boston Suburban Office market recorded 320,388 sq. ft. of positive absorption, as considerable activity in the Metro West bolstered the market, much of which was holdover from slow-moving deals in 2016.
Life sciences continued to drive demand, and as tenants began to shift outwards from tighter urban markets, buildings with strong amenities experienced the most success, as the push for quality office space continued to rise.
Availability dropped 20 basis points (bps) quarter-over-quarter to 20.5% as large tenant renewals and organic growth from established companies continued to be a theme.
Despite the decline in availability, vacancy increased 50 bps, quarter-over-quarter, to 18.1%, while rents remained relatively flat, ending Q1 2017 at $22.78 per sq. ft.
Short on time? Here are the highlights of our first quarter Cambridge Office/Lab MarketView. To request the full report, fill out the form at the bottom of this post.
With the question of the day being whether the market has reached its peak, many have pointed to the fact that Boston rents are still well below their 2008 peak as evidence that there is still room to run. But does Boston proper alone still present the full picture of the market, or has the epicenter of demand shifted to the other side of the Charles?
The rental spike in Boston that preceded the 2008 collapse saw growth of 89.9% from trough to peak. By comparison, East Cambridge office rents have grown 110.1% since 2011. Whether Cambridge is the new bellwether of the Boston market remains to be seen, but signs of caution have already been sighted in the city.
This is not to say the Cambridge Office market is struggling by any definition. Indeed, the first quarter statistics remained robust across the board. Asking rents—already the highest in Greater Boston— continued to see very slight upward growth, absorption was in the black and vacancy was only 3.6%.
In the last few years, finding lab space in Cambridge has been challenging even for those that could afford it. In response, developers and investors have been rapidly putting steel in the air, and more have plans underway to do the same.
At North Point, DivcoWest’s new megaproject near Lechmere, 430,000 sq. ft. of lab space is on the table, while other buildings spearheaded by MIT and Alexandria are already underway to service the pent-up lab demand.
But much like the office side, Cambridge lab demand has been waning of late, leading some to wonder whether these new projects will come online too late in the cycle and only exacerbate a softening market.